Effect of Dapagliflozin on Renal Oxygen Delivery and Consumption in T2DM and NGT Subjects

被引：0
|
作者：
Tripathy, Devjit
Chen, Xi
Chilton, Robert
Hansis-Diarte, Andrea A.
Salehi, Marzieh
Solis-Herrera, Carolina
Cersosimo, Eugenio
Defronzo, Ralph A.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-869-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
869-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects
    Chen, Xi
    Solis-Herrera, Carolina
    Tripathy, Devjit
    Hansis-Diarte, Andrea A.
    Chilton, Robert
    Cersosimo, Eugenio
    Defronzo, Ralph A.
    DIABETES, 2022, 71
  • [2] Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects
    Chen, Xi
    Tripathy, Devjit
    Chilton, Robert
    Hansis-Diarte, Andrea
    Salehi, Marzieh
    Solis-Herrera, Carolina
    Cersosimo, Eugenio
    DeFronzo, Ralph A.
    DIABETES, 2024, 73 (06) : 896 - 902
  • [3] Critical evaluation of insulin secretion in NGT, IGT, and T2DM subjects
    Defronzo, R
    Gastaldelli, A
    Miyazaki, Y
    Matsuda, M
    Mari, A
    Ferrannini, E
    DIABETES, 2003, 52 : A335 - A335
  • [4] Cardio- renal Effect Of Dapagliflozin Alone Versus Dapagliflozin- Saxagliptin Combination In Type 2 Diabetes ( t2dm) Subjects
    Nandula, Seshagiri Rao R.
    Sen, Sabyasachi
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [5] Dapagliflozin—redefining treatment of T2DM?
    Edward C. Chao
    Nature Reviews Endocrinology, 2011, 7 : 696 - 697
  • [6] Effect of Dapagliflozin on renal and hepatic glucose kinetics in type 2 diabetes and NGT subjects
    Tripathy, D.
    Solis-Herrera, C.
    Chen, X.
    Hansis-Diarte, A.
    Chilton, R.
    DeFronzo, R.
    Cersosimo, E.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S7 - S7
  • [7] Safety of Dapagliflozin in Clinical Trials for T2DM
    Ptaszynska, Agata
    Johnsson, Kristina M.
    Apanovitch, Anne Marie
    Sugg, Jennifer E.
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2012, 61 : A258 - A259
  • [8] DIABETES Dapagliflozin-redefining treatment of T2DM?
    Chao, Edward C.
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (12) : 696 - 697
  • [9] Dapagliflozin associated with higher risk of ketoacidosis in T2DM patients
    Reactions Weekly, 2022, 1900 (1) : 6 - 6
  • [10] Dapagliflozin Is Safe and Well Tolerated in Older Patients with T2DM
    Mansfield, Traci
    Fioretto, Paola
    Ptaszynska, Agata
    Yavin, Yshai
    Apanovitch, Anne Marie
    Johnsson, Eva
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2014, 63 : A71 - A71
12345